The current status and future perspectives of iPSC technology-based regenerative medicine for kidney diseases.
—iPSC technology-based regenerative medicine for kidney diseases—
A review article on the research iPSC technology-based regenerative medicine for kidney diseases by Kenji Osafune, our chief scientific advisor, was published on March 3, 2021 in ” Clinical and Experimental Nephrology ”
https://link.springer.com/article/10.1007%2Fs10157-021-02030-x